SPY305.95+0.40 0.13%
DIA256.49+1.22 0.48%
IXIC9,504.99-47.06 -0.49%

Morgan Stanley Maintains Equal-Weight on Global Blood Therapeutics, Raises Price Target to $75

Morgan Stanley maintains Global Blood Therapeutics (NASDAQ:GBT) with a Equal-Weight and raises the price target from $70 to $75.

Benzinga · 05/07/2020 11:59

Morgan Stanley maintains Global Blood Therapeutics (NASDAQ:GBT) with a Equal-Weight and raises the price target from $70 to $75.